期刊文献+

环泊酚联合瑞芬太尼在腔镜胃癌根治术麻醉中的有效性与安全性

Effectiveness and Safety Analysis of Cyclopol Combined with Remifentanil in Anesthesia for Endoscopic Gastric Cancer Radical Surgery
下载PDF
导出
摘要 目的 探讨环泊酚联合瑞芬太尼在腔镜胃癌根治术麻醉中的有效性与安全性。方法 将2022年8月至2023年7月在中国人民解放军联勤保障部队第九〇〇医院收治的100例腔镜胃癌根治术患者随机分成丙泊酚联合瑞芬太尼组与环泊酚联合瑞芬太尼组,丙泊酚联合瑞芬太尼组50例予以丙泊酚联合瑞芬太尼麻醉,环泊酚联合瑞芬太尼组50例予以环泊酚联合瑞芬太尼麻醉,比较2组的生命体征(呼吸频率、心率、血氧饱和度)、麻醉指标(麻醉起效时间、自主呼吸恢复时间、苏醒时间、离室时间)、麻醉效果以及不良反应(注射痛、低血压、低氧血症、呼吸抑制、头晕、嗜睡)。结果 呼吸频率在2组间、时点间、组间·时点间的交互作用,差异无统计学意义(P> 0.05);心率、血氧饱和度在2组间、时点间、组间·时点间的交互作用,差异有统计学意义(P <0.05);2组T0-T5的呼吸频率比较,差异无统计学意义(P> 0.05);环泊酚联合瑞芬太尼组T1、T2的心率高于丙泊酚联合瑞芬太尼组,差异有统计学意义(P <0.05),2组其他时间的心率比较,差异无统计学意义(P> 0.05);环泊酚联合瑞芬太尼组T2的血氧饱和度高于丙泊酚联合瑞芬太尼组,差异有统计学意义(P <0.05),2组其他时间的血氧饱和度比较,差异无统计学意义(P> 0.05)。2组麻醉起效时间比较,差异无统计学意义(P>0.05);环泊酚联合瑞芬太尼组自主呼吸恢复时间、苏醒时间、离室时间短于丙泊酚联合瑞芬太尼组,差异有统计学意义(P <0.05)。环泊酚联合瑞芬太尼组总有效率为96.00%,高于丙泊酚联合瑞芬太尼组的84.00%,差异有统计学意义(P <0.05)。环泊酚联合瑞芬太尼组不良反应发生率为10.00%,低于丙泊酚联合瑞芬太尼组的28.00%,差异有统计学意义(P <0.05)。结论 环泊酚联合瑞芬太尼在腔镜胃癌根治术麻醉中的应用效果较好,能够稳定患者术中生命体征,改善麻醉指标,减少不良反应,可推行。 Objective To investigate the effectiveness and safety of cyclophenol combined with remifentanil in anesthesia for laparoscopic radical gastrectomy for gastric cancer.Methods A total of 100 patients who underwent laparoscopic radical gastrectomy for gastric cancer admitted to 900 Hospital of the Joint Logistic Support Force from August 2022 to July 2023 were randomly divided into two groups:the propofol combined with remifentanil group(50 cases) received propofol combined with remifentanil anesthesia,and the cyclopol combined with remifentanil group( 50 cases) received cyclophenol combined with remifentanil anesthesia.The vital signs(respiratory rate,heart rate,and blood oxygen saturation) of the two groups of patients were observed.Anesthesia indicators(onset time of anesthesia,recovery time of spontaneous breathing,awakening time,time of leaving the room),anesthesia effect,and adverse reactions(Injection pain,hypotension,hypoxemia,respiratory depression,dizziness,drowsiness) were also observed.Results The interaction effect of respiratory rate between two groups,time points,and between groups/time points showed no statistically significant difference( P > 0.05);The interaction between heart rate and blood oxygen saturation between two groups,time points,and between groups and time points showed statistically significant differences(P < 0.05).There was no statistically significant difference(P > 0.05) in the respiratory rate between the two groups of T0 to T5.The heart rate of T1 and T2 in the combination of propofol and remifentanil group was higher than that in the combination of propofol and remifentanil group,and the difference was statistically significant(P < 0.05).There was no statistically significant difference in heart rate between the two groups at other times(P > 0.05).The blood oxygen saturation of T2 in the combination of propofol and remifentanil group was higher than that in the combination of propofol and remifentanil group,and the difference was statistically significant(P < 0.05).There was no statistically significant difference in blood oxygen saturation between the two groups at other times(P > 0.05).There was no statistically significant difference in the onset time of anesthesia between the two groups(P > 0.05).The spontaneous breathing recovery time,awakening time,and departure time of the group treated with propofol combined with remifentanil were shorter than those of the group treated with propofol combined with remifentanil,and the differences were statistically significant(P < 0.05).The total effective rate of the combination of propofol and remifentanil group was 96.00%,which was higher than the84.00% of the combination of propofol and remifentanil group,and the difference was statistically significant(P <0.05).The incidence of adverse reactions in the combination of propofol and remifentanil group was 10.00%,which was lower than the 28.00% in the combination of propofol and remifentanil group,and the difference was statistically significant(P < 0.05).Conclusion The application of cyclophorol combined with remifentanil in anesthesia for laparoscopic radical gastrectomy for gastric cancer has a good effect,can stabilize the patient's intraoperative vital signs,improve anesthesia indicators,reduce adverse reactions,and can be promoted.
作者 王克棪 林冰婷 翁晓琳 黄滨 王烈 WANG Keyan;LIN Bingting;WENG Xiaolin;HUANG Bin;WANG Lie(Department of Anesthesiology and Perioperative Medicine,900th Hospital of Joint Logistic Support Force,PLA,PLA,Fujian 350001;General surgery,900th Hospital of Joint Logistic Support Force,PLA,Fuzhou Fujian 350001,China)
出处 《昆明医科大学学报》 CAS 2024年第6期154-160,共7页 Journal of Kunming Medical University
基金 福建省自然科学基金资助项目(2020J011138)。
关键词 环泊酚 瑞芬太尼 腔镜胃癌根治术 麻醉 有效性 安全性 Cyclophenol Remifentanil Endoscopic radical gastrectomy for gastric cancer Anesthesia Effectiveness Security
  • 相关文献

参考文献22

二级参考文献169

  • 1谭卫卫,王祥,郭宗峰,陈为国.舒芬联合瑞芬太尼靶控输注对结直肠癌根治术患者的疗效及对其疼痛应激及血流动力学的影响分析[J].湖南师范大学学报(医学版),2020,17(3):111-114. 被引量:7
  • 2Ajani JA,Bekaii-Saab T,Yang G. NCCN clinical practice guidelines in oncology:gastric cancer[M].2009.
  • 3Karam SM. Cellular origin of gastric cancer[J].Ann N Y Aced Sci,2008.162-168.
  • 4Hamashima C,Shibuya D,Yamazaki H. The Japaneseguidelines for gastric cancer screening[J].Jpn 1 Clin Oncol,2008,(04):259-267.
  • 5Leung WK,Wu MS,Kakugawa Y. Asia Pacific WorkingGroup on Gastric Cancer.Screening for gastric cancer in Asia:current evidence and practice[J].{H}LANCET ONCOLOGY,2008,(03):279-287.
  • 6Jatzko GR,Lisborg PH,Denk H. A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan[J].{H}CANCER,1995,(08):1302-1312.
  • 7Parkin DM,Bray F,Ferlay J. Global cancer statistics,2002[J].{H}CA-A Cancer Journal for Clinicians,2005,(02):74-108.
  • 8Sierra A,Regueira FM,Hernlxndez-LiwGin JL. Role of the extended lymphadenectomy in gastric cancer surgery:experience in a single institution[J].{H}ANNALS OF SURGICAL ONCOLOGY,2003,(03):219-226.
  • 9董志伟;谷铣之.临床肿瘤学[M]{H}北京:人民卫生出版社,20029-27.
  • 10Enzinger PC,Benedetti JK,Meyerhardt JA. Impact of hospital volume on recurrence and survival after surgery for gastnc cancer[J].2007,(03):426-434.

共引文献542

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部